tiprankstipranks
Trending News
More News >
Cymat Technologies Ltd (TSE:CYM)
:CYM
Canadian Market

Cymat Technologies (CYM) AI Stock Analysis

Compare
12 Followers

Top Page

TS

Cymat Technologies

(CYM)

Rating:53Neutral
Price Target:
C$0.00
▼(-100.00%Downside)
Cymat Technologies' overall score is driven by its challenging financial performance and valuation concerns. However, positive corporate events offer potential growth opportunities, slightly offsetting the financial risks. Technical analysis suggests mixed market sentiment, contributing to a moderate overall score.

Cymat Technologies (CYM) vs. iShares MSCI Canada ETF (EWC)

Cymat Technologies Business Overview & Revenue Model

Company DescriptionCymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company provides architectural materials under the Alusion brand name; and automotive and blast mitigation products under the SmartMetal brand name. It serves defense and military, automotive and transportation, architectural, and other application. The company was incorporated in 2006 and is based in Mississauga, Canada.
How the Company Makes MoneyCymat Technologies generates revenue primarily through the sale of its stabilized aluminum foam products. The company targets multiple industries, leveraging its technology to meet specific needs such as energy absorption in automotive crash management systems, acoustic and thermal insulation in architecture, and lightweight armor solutions for military applications. Key revenue streams include direct sales to manufacturers, as well as licensing agreements and partnerships that expand its market reach. Significant partnerships with industry leaders enhance Cymat's market presence and provide opportunities for collaborative product development, further driving sales and revenue growth.

Cymat Technologies Financial Statement Overview

Summary
Cymat Technologies faces significant financial challenges, with consistent losses, negative equity, and reliance on external financing. While there is some revenue growth in the latest period, the overall financial health is weak, characterized by high leverage and negative cash flows.
Income Statement
25
Negative
Cymat Technologies has experienced declining revenues and profitability over recent periods. The TTM data shows negative EBIT and EBITDA margins, indicating operational challenges. The net profit margin is also negative, suggesting persistent losses. Despite some revenue growth in the latest TTM period, the overall financial performance remains weak.
Balance Sheet
20
Very Negative
The company has a negative stockholders' equity, indicating financial distress. The debt-to-equity ratio is not calculable due to negative equity, but liabilities far exceed assets, highlighting a precarious financial position. The equity ratio is also negative, demonstrating significant leverage and risk.
Cash Flow
30
Negative
Operating and free cash flows are negative, reflecting cash burn from operations and insufficient cash generation. The operating cash flow to net income ratio is unfavorable due to both metrics being negative. The company relies heavily on financing activities to cover cash shortfalls.
Breakdown
TTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income StatementTotal Revenue
2.79M1.62M3.05M3.12M4.15M1.69M
Gross Profit
374.30K-412.85K-270.42K795.48K2.12M373.27K
EBIT
-2.66M-3.86M-5.56M-4.34M62.45K-1.69M
EBITDA
-2.25M-3.36M-5.45M-4.23M252.17K-1.51M
Net Income Common Stockholders
-3.36M-4.27M-6.05M-4.75M-543.00K-1.81M
Balance SheetCash, Cash Equivalents and Short-Term Investments
211.33K56.27K324.05K2.47M5.02M251.58K
Total Assets
3.49M3.96M4.16M6.17M6.58M1.86M
Total Debt
4.68M2.94M2.28M1.02M1.10M1.06M
Net Debt
4.46M2.89M1.95M-1.45M-3.92M810.37K
Total Liabilities
7.77M6.78M4.77M3.83M3.71M2.75M
Stockholders Equity
-4.28M-2.81M-612.07K2.34M2.88M-889.52K
Cash FlowFree Cash Flow
-1.51M-2.26M-3.49M-4.53M401.48K-1.38M
Operating Cash Flow
-1.46M-2.23M-2.46M-4.32M432.92K-1.33M
Investing Cash Flow
-48.18K-31.32K-1.03M-534.54K-31.44K-47.92K
Financing Cash Flow
1.51M1.99M1.35M2.30M4.36M1.45M

Cymat Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.12
Price Trends
50DMA
0.12
Positive
100DMA
0.13
Negative
200DMA
0.12
Negative
Market Momentum
MACD
<0.01
Negative
RSI
54.24
Neutral
STOCH
77.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Positive. The current price of 0.12 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.12, and below the 200-day MA of 0.12, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.24 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CYM.

Cymat Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TSDRX
82
Outperform
C$188.08M3.4234.27%0.60%2.60%59.86%
62
Neutral
$11.72B10.43-7.10%2.91%7.41%-7.94%
TSCYM
53
Neutral
C$8.21M78.34%81.96%42.19%
TSIB
44
Neutral
C$7.44M34.86%
TSIOT
C$13.33M33.9722.65%
TSIVX
51
Neutral
C$4.29M37.934.29%4.99%112.84%
$5.23M
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CYM
Cymat Technologies
0.12
-0.04
-25.00%
TSE:DRX
ADF Group Inc. SV
6.70
-10.00
-59.88%
TSE:IB
IBC Advanced Alloys
0.06
-0.02
-25.00%
TSE:IOT
Innovotech
0.26
0.18
225.00%
TSE:IVX
Inventronics
0.88
0.23
35.38%
IPNFF
ImagineAR
0.02
>-0.01
-33.33%

Cymat Technologies Corporate Events

Business Operations and Strategy
Cymat Technologies Secures 10-Year Partnership with NUVIA in Nuclear Sector
Positive
Apr 30, 2025

Cymat Technologies Ltd. has entered into a 10-year collaboration agreement with NUVIA, a French company in the nuclear energy sector, to integrate Cymat’s SmartMetal panels into NUVIA’s Nufoam systems. This partnership aims to enhance Cymat’s market presence in the nuclear industry, especially as nuclear energy gains traction as a low-carbon energy source. The agreement is expected to support Cymat’s revenue growth and strengthen its position in the industry, benefiting stakeholders through increased sales and joint marketing initiatives.

Private Placements and FinancingBusiness Operations and Strategy
Cymat Technologies Secures $1.3 Million Private Placement Approval
Positive
Apr 15, 2025

Cymat Technologies Ltd. has secured approval from the TSX Venture Exchange for a $1.3 million private placement financing. The funds will be used for capital equipment purchases and working capital, supporting a strategic business development initiative. This move is expected to enhance Cymat’s operational capabilities and strengthen its market position.

Private Placements and FinancingBusiness Operations and Strategy
Cymat Technologies Secures $1.3 Million in Private Placement Financing
Positive
Apr 9, 2025

Cymat Technologies Ltd. has successfully completed a non-brokered private placement financing, raising approximately $1.3 million. The funds will be used to purchase capital equipment supporting a major strategic business development initiative and to provide additional working capital for ongoing strategic automotive initiatives. This financing positions Cymat to capitalize on strategic opportunities and enhance its operational capabilities in the automotive sector.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.